Sinovac Biotech Ltd. (SVA) Fundamentals

Sinovac Biotech Ltd is a biopharmaceutical company. The company primarily focuses on the research, development, manufacturing, and commercialization of vaccines for infectious diseases. Its product portfolio includes vaccines against hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), mumps, and canine rabies. The company also provides services for disease control and prevention, collaborating with the Chinese governments at the national, state and local levels. Sinovac primarily sells its vaccines in China, while also exploring growth opportunities in international markets.
SHARE INFORMATION
Market Cap$ 643,779,512
Shares Outstanding99,502,243
Float71,831,484
Percent Float72.19%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 19,374,904,000
Latest Fiscal EPS$ 74.27
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions38
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months107
Institutional Holdings Percent12.5%
Institutional Sold Previous 3 Months2,141
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 0.00
52 Week Low$ 0.00
52 Week High Change$ 0.00
21 Day Moving Average$ 0.00
21 Day Extended Moving Average$ 6.47
50 Day Moving Average$ 0.00
50 Day Extended Moving Average$ 6.47
200 Day Moving Average$ 0.00
200 Day Extended Moving Average$ 6.4701
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume-
50 Day Average Volume-
Alpha0.007166
Beta0.3045
Standard Deviation0.077984
R20.021571
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ 0.00
180 Day Percent Change0.0%
200 Day Price Change$ 0.00
200 Day Percent Change0.0%
Year to Date Price Change$ 0.00
Year to Date Percent Change0.0%

Sinovac Biotech Ltd. (SVA) Key Ratios

PROFITABILITY
EBIT Margin90.7%
EBITDA Margin91.1%
Pre-Tax Profit Margin42.6%
Profit Margin Count74.63%
Gross Margin94.5%
Profit Margin TOT74.63%
INCOME STATEMENTS
Revenue$ 19,374,904,000
Revenue Per Share$ 194.7183
Revenue (3 Years)$ 132.08
Revenue (5 Years)$ 104.88
FINANCIAL STRENGTH
Price to Tangible Book0.10
Total Debt To Equity0.00
Int Coverage6,193.90
Current Ratio6.20
Leverage Ratio1.80
Quick Ratio6.00
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio0.10
Enterprise Value$ 297,087,285
Price to Sales0.033227
Price to Free Cash0.10
PE High Last 5 Years20.90
Price To Book0.00
Price To Cash Flow52.90
PE Low Last 5 Years-460.00
Price to Tangible Book0.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover32.60
Invoice Turnover4.50
Assets Turnover2.10
Return Assets91.39
Return on Equity168.85
Return on Capital161.84

Sinovac Biotech Ltd. (SVA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorGrant Thornton
CEOWeidong Yin
Emplyoees5505
Last AuditUQ
CIK0001084201
IndustryBiotechnology
SectorHealthcare
NAICS-
CONTACT INFO
AddressNo. 15 Zhi Tong Road
Zhongguancun Science & Technology Park
Beijing, 102200
Websitehttp://www.sinovac.com
Facsimile+86 1056931800
Telephone+86 1056931800
Emailir@sinovac.com


Your Recent History
NASDAQ
SVA
Sinovac Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.